Table 3. Correlation of combination of ALDH1 and CD44 expression score with clinicopathological features in endometrial carcinoma.
| Both | At least one | Both | ||
|---|---|---|---|---|
| Characteristic | ≤ median | > median | > median | P value |
| Patients (no.) | 36 | 38 | 18 | |
| Age range (years) | 31–77 | 40–83 | 33–88 | 0.162 |
| Mean ± SEM | 52.72±1.67 | 56.16±1.77 | 58.89±3.63 | |
| FIGO Stage [no. (%)] | 0.777 | |||
| I, II | 26 (41.3) | 25 (39.7) | 12 (19.0) | |
| III | 9 (33.3) | 12 (44.4) | 6 (22.3) | |
| Nuclear grade [no. (%)] | 0.048 | |||
| Grade 1 | 21 (53.85) | 14 (35.90) | 4 (10.26) | |
| Grade 2 | 8 (29.63) | 14 (51.85) | 5 (18.52) | |
| Grade 3 | 7 (26.92) | 10 (38.46) | 9 (34.62) | |
| Histological type [no. (%)] | 0.165a | |||
| Clear cell carcinoma | 1 (16.67) | 2 (33.33) | 3 (50.00) | |
| Endometrioid Adenocarcinom | 30 (41.67) | 31 (43.06) | 11 (15.28) | |
| Mucinous Carcinoma | 2 (100.00) | 0 (0) | 0 (0) | |
| Serous Carcinoma | 3 (25.00) | 5 (41.67) | 4 (33.33) | |
| Histological type [no. (%)] | 0.059 | |||
| Type I EC (EmAC G1 and G2) + MC | 29 (43.9) | 28 (42.5) | 9 (13.6) | |
| Type II EC (CC, SC) + EmAC G3 | 7 (26.9) | 10 (38.5) | 9 (34.6) |
a Fisher’s exact test.
SEM: standard error of the mean, CC: clear cell carcinoma; EmAC: endometrioid adenocarcinoma; MC: mucinous carcinoma; SC: serous carcinoma.